Sporos Bioventures
Peter Feinberg is a co-founder of BridgeBio Pharma and a Founding Partner at Boxcar Partners. Peter is also an advisor and board observer of Immuneering Corporation, a M.A. based Biotech company. Peter brings over 30 years in the financial services sector to the Sporos team, having served as a Managing Director and Head of Institutional Equities Trading at Oppenheimer & Co. He attended Whittier College for his undergraduate degree.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Sporos Bioventures
Sporos is transforming knowledge into new hope for patients. With deep roots in Texas, connections within Texas Medical Center (TMC) and reach across the industry, the Company identifies novel disease mechanisms and strategically deploys talent, capital and access to operational resources to catalyze the development of breakthrough medicines. Sporos’ current pipeline is diversified across four entities and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease.